These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28939855)

  • 1. Infection with Burkholderia pseudomallei - immune correlates of survival in acute melioidosis.
    Dunachie SJ; Jenjaroen K; Reynolds CJ; Quigley KJ; Sergeant R; Sumonwiriya M; Chaichana P; Chumseng S; Ariyaprasert P; Lassaux P; Gourlay L; Promwong C; Teparrukkul P; Limmathurotsakul D; Day NPJ; Altmann DM; Boyton RJ
    Sci Rep; 2017 Sep; 7(1):12143. PubMed ID: 28939855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute Melioidosis.
    Reynolds C; Goudet A; Jenjaroen K; Sumonwiriya M; Rinchai D; Musson J; Overbeek S; Makinde J; Quigley K; Manji J; Spink N; Yos P; Wuthiekanun V; Bancroft G; Robinson J; Lertmemongkolchai G; Dunachie S; Maillere B; Holden M; Altmann D; Boyton R
    J Immunol; 2015 May; 194(10):4814-24. PubMed ID: 25862821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T
    Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG
    mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis.
    Chu KK; Tippayawat P; Walker NJ; Harding SV; Atkins HS; Maillere B; Bancroft GJ; Lertmemongkolchai G; Altmann DM
    Eur J Immunol; 2011 Jan; 41(1):107-15. PubMed ID: 21182082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melioidosis Patient Survival Correlates With Strong IFN-γ Secreting T Cell Responses Against Hcp1 and TssM.
    Sengyee S; Yarasai A; Janon R; Morakot C; Ottiwet O; Schmidt LK; West TE; Burtnick MN; Chantratita N; Brett PJ
    Front Immunol; 2021; 12():698303. PubMed ID: 34394091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-Cell Responses Are Associated with Survival in Acute Melioidosis Patients.
    Jenjaroen K; Chumseng S; Sumonwiriya M; Ariyaprasert P; Chantratita N; Sunyakumthorn P; Hongsuwan M; Wuthiekanun V; Fletcher HA; Teparrukkul P; Limmathurotsakul D; Day NP; Dunachie SJ
    PLoS Negl Trop Dis; 2015 Oct; 9(10):e0004152. PubMed ID: 26495852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.
    Musson JA; Reynolds CJ; Rinchai D; Nithichanon A; Khaenam P; Favry E; Spink N; Chu KK; De Soyza A; Bancroft GJ; Lertmemongkolchai G; Maillere B; Boyton RJ; Altmann DM; Robinson JH
    J Immunol; 2014 Dec; 193(12):6041-9. PubMed ID: 25392525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome wide transcriptome profiling of a murine acute melioidosis model reveals new insights into how Burkholderia pseudomallei overcomes host innate immunity.
    Chin CY; Monack DM; Nathan S
    BMC Genomics; 2010 Nov; 11():672. PubMed ID: 21110886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkholderia pseudomallei Δ
    Khakhum N; Bharaj P; Myers JN; Tapia D; Kilgore PB; Ross BN; Walker DH; Endsley JJ; Torres AG
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30602524
    [No Abstract]   [Full Text] [Related]  

  • 10. BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis.
    Tomás-Cortázar J; Bossi L; Quinn C; Reynolds CJ; Butler DK; Corcoran N; Murchú MÓ; McMahon E; Singh M; Rongkard P; Anguita J; Blanco A; Dunachie SJ; Altmann D; Boyton RJ; Arnold J; Giltaire S; McClean S
    Front Immunol; 2021; 12():767359. PubMed ID: 34966388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Control of
    Nithichanon A; Rinchai D; Buddhisa S; Saenmuang P; Kewcharoenwong C; Kessler B; Khaenam P; Chetchotisakd P; Maillere B; Robinson J; Reynolds CJ; Boyton RJ; Altmann DM; Lertmemongkolchai G
    Front Immunol; 2018; 9():484. PubMed ID: 29616023
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.
    Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW
    Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to Burkholderia pseudomallei induces cell-mediated immunity in healthy individuals.
    Govan B; Ketheesan N
    Clin Microbiol Infect; 2004 Jun; 10(6):585-7. PubMed ID: 15191392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis.
    Swetha RG; Sandhya M; Ramaiah S; Anbarasu A
    J Theor Biol; 2016 Jul; 400():11-8. PubMed ID: 27086038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens.
    Barnes JL; Ketheesan N
    Immunol Cell Biol; 2007 Oct; 85(7):551-7. PubMed ID: 17563759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei.
    Tippayawat P; Saenwongsa W; Mahawantung J; Suwannasaen D; Chetchotisakd P; Limmathurotsakul D; Peacock SJ; Felgner PL; Atkins HS; Titball RW; Bancroft GJ; Lertmemongkolchai G
    PLoS Negl Trop Dis; 2009; 3(4):e407. PubMed ID: 19352426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to Burkholderia pseudomallei.
    Panomket P
    J Med Assoc Thai; 2011 Nov; 94(11):1410-7. PubMed ID: 22256484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive immunity in melioidosis: a possible role for T cells in determining outcome of infection with Burkholderia pseudomallei.
    Barnes JL; Warner J; Melrose W; Durrheim D; Speare R; Reeder JC; Ketheesan N
    Clin Immunol; 2004 Oct; 113(1):22-8. PubMed ID: 15380526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Burkholderia mallei and pseudomallei vaccines.
    Silva EB; Dow SW
    Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed activation of host innate immune pathways in streptozotocin-induced diabetic hosts leads to more severe disease during infection with Burkholderia pseudomallei.
    Chin CY; Monack DM; Nathan S
    Immunology; 2012 Apr; 135(4):312-32. PubMed ID: 22136109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.